Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Furio Colivicchi, Catarina Sternhufvud & Sanjay K Gandhi. (2015) Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials. ClinicoEconomics and Outcomes Research 7, pages 555-565.
Read now
Read now
Charles Andy Schuetz, Siew Hwa Ong & Matthias Blüher. (2015) Clinical trial simulation methods for estimating the impact of DPP-4 inhibitors on cardiovascular disease. ClinicoEconomics and Outcomes Research 7, pages 313-323.
Read now
Read now
Andrew van Herick, C Andy Schuetz, Peter Alperin, Michael F Bullano, Sanjeev Balu & Sanjay Gandhi. (2012) The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model. ClinicoEconomics and Outcomes Research 4, pages 337-347.
Read now
Read now
Articles from other publishers (10)
Ruotong Yang, Junhui Wu, Huan Yu, Siyue Wang, Hongbo Chen, Mengying Wang, Xueying Qin, Tao Wu, Yiqun Wu & Yonghua Hu. (2023) Is statin therapy after ischaemic stroke associated with increased intracerebral hemorrhage? The association may be dependent on intensity of statin therapy. International Journal of Stroke, pages 174749302311726.
Crossref
Crossref
Alaa Rahhal, Fadi Khir, Bassant Orabi, Salma Chbib, Osama Al-Khalaila, Mohamed Salah Abdelghani, Omnia Osman, Amr Azzam Ashour, Mohammad Al-Awad, Ahmed Mahfouz, Ahmed Awaisu, Amer Hussien Aljundi, Yaser Alahmad, Sumaya Alyafei & Abdul Rahman Arabi. (2022) A Comparative Study of High-intensity Rosuvastatin Versus Atorvastatin Therapy Post-acute Coronary Syndrome Using Real-world Data. Current Problems in Cardiology 47:7, pages 100956.
Crossref
Crossref
Arim Kwak, Jae Hyun Kim, Cheol Ung Choi, In-Wha Kim, Jung Mi Oh & Kyungim Kim. (2019) Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over. International Journal of Clinical Pharmacy 41:2, pages 460-469.
Crossref
Crossref
Wang Zhao, Zhi-Jie Xiao & Shui-Ping Zhao. (2019) The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature. Neurology India 67:4, pages 983.
Crossref
Crossref
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous & M. Kamal. (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome. Rational Pharmacotherapy in Cardiology 14:5, pages 636-645.
Crossref
Crossref
Matthias Egger, Leigh Johnson, Christian Althaus, Anna Schöni, Georgia Salanti, Nicola Low & Susan L. Norris. (2018) Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies. F1000Research 6, pages 1584.
Crossref
Crossref
Matthias Egger, Leigh Johnson, Christian Althaus, Anna Schöni, Georgia Salanti, Nicola Low & Susan L. Norris. (2017) Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies. F1000Research 6, pages 1584.
Crossref
Crossref
Klea Panayidou, Sandro Gsteiger, Matthias Egger, Gablu Kilcher, Máximo Carreras, Orestis Efthimiou, Thomas P. A. Debray, Sven Trelle & Noemi Hummel. (2016) GetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world. Research Synthesis Methods 7:3, pages 264-277.
Crossref
Crossref
Henry Folse, Catarina Sternhufvud, C. Andy Schuetz, Badri Rengarajan & Sanjay Gandhi. (2014) Impact of Switching Treatment From Rosuvastatin to Atorvastatin on Rates of Cardiovascular Events. Clinical Therapeutics 36:1, pages 58-69.
Crossref
Crossref
Zhengzhong Wang, Hongyan Dai, Mingqing Xing, Zhongxiang Yu, Xianru Lin, Shoudong Wang, Junyi Zhang, Fangjie Hou, Ying Ma, Yongqiang Ren, Kai Tan, Yanping Wang & Zhiming Ge. (2013) Effect of a Single High Loading Dose of Rosuvastatin on Percutaneous Coronary Intervention for Acute Coronary Syndromes. Journal of Cardiovascular Pharmacology and Therapeutics 18:4, pages 327-333.
Crossref
Crossref